Molecular mechanisms underlying chemical liver injury

The liver is necessary for survival. Its strategic localisation, blood flow and prominent role in the metabolism of xenobiotics render this organ particularly susceptible to injury by chemicals to which we are ubiquitously exposed. The pathogenesis of most chemical-induced liver injuries is initiated by the metabolic conversion of chemicals into reactive intermediate species, such as electrophilic compounds or free radicals, which can potentially alter the structure and function of cellular macromolecules. Many reactive intermediate species can produce oxidative stress, which can be equally detrimental to the cell. When protective defences are overwhelmed by excess toxicant insult, the effects of reactive intermediate species lead to deregulation of cell signalling pathways and dysfunction of biomolecules, leading to failure of target organelles and eventual cell death. A myriad of genetic factors determine the susceptibility of specific individuals to chemical-induced liver injury. Environmental factors, lifestyle choices and pre-existing pathological conditions also have roles in the pathogenesis of chemical liver injury. Research aimed at elucidating the molecular mechanism of the pathogenesis of chemical-induced liver diseases is fundamental for preventing or devising new modalities of treatment for liver injury by chemicals.

[1]  G. Poli,et al.  The role of lipid peroxidation in liver damage. , 1987, Chemistry and physics of lipids.

[2]  N. Kaplowitz,et al.  Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. , 2006, American journal of physiology. Gastrointestinal and liver physiology.

[3]  C. Cross,et al.  Oxygen-derived species: their relation to human disease and environmental stress. , 1994, Environmental health perspectives.

[4]  J. Farber,et al.  Mechanisms of cell injury by activated oxygen species. , 1994, Environmental health perspectives.

[5]  Magnus Ingelman-Sundberg,et al.  The Human Cytochrome P450 (CYP) Allele Nomenclature website: a peer-reviewed database of CYP variants and their associated effects , 2010, Human Genomics.

[6]  D A Smith,et al.  Role of reactive metabolites in drug-induced hepatotoxicity. , 2010, Handbook of experimental pharmacology.

[7]  H. Zimmerman,et al.  Hepatotoxicity: The adverse effects of drugs and other chemicals on the liver , 1978 .

[8]  Mark Feldman,et al.  Sleisenger and Fordtran's gastrointestinal and liver disease , 2012 .

[9]  S. Hsia,et al.  Macromolecular adducts: biomarkers for toxicity and carcinogenesis. , 1994, Annual review of pharmacology and toxicology.

[10]  Jianghong Fan,et al.  Interplay of transporters and enzymes in drug and metabolite processing. , 2009, Molecular pharmaceutics.

[11]  P. Ghezzi,et al.  Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. , 2005, Antioxidants & redox signaling.

[12]  J. Hiatt,et al.  Acetaminophen hepatotoxicity and acute liver failure. , 2009, Journal of clinical gastroenterology.

[13]  R. G. Allen,et al.  Oxidative stress and gene regulation. , 2000, Free radical biology & medicine.

[14]  R. Zangar,et al.  Mechanisms that regulate production of reactive oxygen species by cytochrome P450. , 2004, Toxicology and applied pharmacology.

[15]  Shufeng Zhou Drugs behave as substrates, inhibitors and inducers of human cytochrome P450 3A4. , 2008, Current drug metabolism.

[16]  Neil Kaplowitz,et al.  Idiosyncratic drug hepatotoxicity , 2005, Nature Reviews Drug Discovery.

[17]  M. Olivier A haplotype map of the human genome , 2003, Nature.

[18]  M. Daly,et al.  HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin , 2009, Nature Genetics.

[19]  A. Kong,et al.  Nrf2 plays an important role in coordinated regulation of Phase II drug metabolism enzymes and Phase III drug transporters. , 2009, Biopharmaceutics & drug disposition.

[20]  R. Gebhardt Metabolic zonation of the liver: regulation and implications for liver function. , 1992, Pharmacology & therapeutics.

[21]  W. Pichler,et al.  Drug interaction with T-cell receptors: T-cell receptor density determines degree of cross-reactivity. , 2004, The Journal of allergy and clinical immunology.

[22]  Hugo O Villar,et al.  Ring systems in mutagenicity databases. , 2005, Journal of medicinal chemistry.

[23]  M. Morgan,et al.  Managing alcohol dependence and alcohol-related liver disease: a problem for the hepatologist, psychiatrist or economist? , 2011, Clinical medicine.

[24]  J. Chipman,et al.  Chloroform, carbon tetrachloride and glutathione depletion induce secondary genotoxicity in liver cells via oxidative stress. , 2003, Toxicology.

[25]  William Stafford Noble,et al.  Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project , 2007, Nature.

[26]  M. Dizdaroglu,et al.  Free radical-induced damage to DNA: mechanisms and measurement. , 2002, Free radical biology & medicine.

[27]  L. Klassen,et al.  Formation and immunological properties of aldehyde-derived protein adducts following alcohol consumption. , 2008, Methods in molecular biology.

[28]  Life Technologies,et al.  A map of human genome variation from population-scale sequencing , 2011 .

[29]  G. Gores,et al.  Hepatocyte death: a clear and present danger. , 2010, Physiological reviews.

[30]  G. Perdew,et al.  Role of the aryl hydrocarbon receptor in drug metabolism , 2005, Expert opinion on drug metabolism & toxicology.

[31]  Benveniste,et al.  Cytochrome P450 , 1993, Handbook of Experimental Pharmacology.

[32]  D. Altshuler,et al.  A map of human genome variation from population-scale sequencing , 2010, Nature.

[33]  J. Lemasters V. Necrapoptosis and the mitochondrial permeability transition: shared pathways to necrosis and apoptosis. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[34]  P. Meier,et al.  Hepatobiliary transporters and drug‐induced cholestasis , 2006, Hepatology.

[35]  Jianwen Fang,et al.  The reactive metabolite target protein database (TPDB) – a web-accessible resource , 2007, BMC Bioinformatics.

[36]  Bernard Testa,et al.  The Biochemistry of Drug Metabolism — An Introduction. Part 2. Redox Reactions and Their Enzymes , 2007 .

[37]  T. Mak,et al.  Essential role of the mitochondrial apoptosis-inducing factor in programmed cell death , 2001, Nature.

[38]  R. Mason,et al.  Free radicals in toxicology. , 1993, Toxicology and applied pharmacology.

[39]  R. Brůha,et al.  Alcoholic liver disease. , 2012, World journal of hepatology.

[40]  T. Sit,et al.  Unique Transcription Start Sites and Distinct Promoter Regions Differentiate the Pregnane X Receptor (PXR) Isoforms PXR 1 and PXR 2 , 2008, Drug Metabolism and Disposition.

[41]  T. Zima,et al.  Oxidative stress and signal transduction pathways in alcoholic liver disease. , 2005, Alcoholism, clinical and experimental research.

[42]  L. Nagy Recent Insights into the Role of the Innate Immune System in the Development of Alcoholic Liver Disease , 2003, Experimental biology and medicine.

[43]  R. Barouki Linking long-term toxicity of xeno-chemicals with short-term biological adaptation. , 2010, Biochimie.

[44]  K. Jungermann,et al.  Zonation of parenchymal and nonparenchymal metabolism in liver. , 1996, Annual review of nutrition.

[45]  A. Kalgutkar Handling reactive metabolite positives in drug discovery: What has retrospective structure-toxicity analyses taught us? , 2011, Chemico-biological interactions.

[46]  Dean P. Jones,et al.  Nuclear and mitochondrial compartmentation of oxidative stress and redox signaling. , 2006, Annual review of pharmacology and toxicology.

[47]  Tak Yee Aw,et al.  Glutathione and apoptosis , 2008, Free radical research.

[48]  G. Gores,et al.  Apoptosis as a mechanism for liver disease progression. , 2010, Seminars in liver disease.

[49]  J. Galligan,et al.  Overview of lipid peroxidation products and hepatic protein modification in alcoholic liver disease. , 2011, Chemico-biological interactions.

[50]  Gary M Williams,et al.  Alteration of Liver Cell Function and Proliferation: Differentiation Between Adaptation and Toxicity , 2002, Toxicologic pathology.

[51]  Dean P. Jones,et al.  Mechanisms of pathogenesis in drug hepatotoxicity putting the stress on mitochondria. , 2010, Molecular interventions.

[52]  C. Martinez-Jimenez,et al.  Transcriptional regulation and expression of CYP3A4 in hepatocytes. , 2007, Current drug metabolism.

[53]  Maria Almira Correia,et al.  Cytochrome P450 regulation: the interplay between its heme* and apoprotein moieties in synthesis, assembly, repair, and disposal , 2011, Drug metabolism reviews.

[54]  Ernesto Callegari,et al.  A comprehensive listing of bioactivation pathways of organic functional groups. , 2005, Current drug metabolism.

[55]  William M. Lee,et al.  Pharmacokinetics of Acetaminophen-Protein Adducts in Adults with Acetaminophen Overdose and Acute Liver Failure , 2009, Drug Metabolism and Disposition.

[56]  Paavo Honkakoski,et al.  Inhibition and induction of human cytochrome P450 enzymes: current status , 2008, Archives of Toxicology.

[57]  R Scott Obach,et al.  Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment. , 2009, Chemical research in toxicology.

[58]  Michael P Holt,et al.  Drug-induced liver injury. , 2010, Handbook of experimental pharmacology.

[59]  Yan Li,et al.  Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development. , 2011, Chemico-biological interactions.

[60]  William M. Lee,et al.  Drug‐induced acute liver failure: Results of a U.S. multicenter, prospective study , 2010, Hepatology.

[61]  P. van Bladeren Glutathione conjugation as a bioactivation reaction. , 2000, Chemico-biological interactions.

[62]  D. Adams,et al.  Mechanisms of immune-mediated liver injury. , 2010, Toxicological Sciences.

[63]  M. Christmann,et al.  Mechanisms of human DNA repair: an update. , 2003, Toxicology.

[64]  J. Boyer,et al.  Bile salt transporters: molecular characterization, function, and regulation. , 2003, Physiological reviews.

[65]  A Kosters,et al.  Bile acid transporters in health and disease. , 2008, Xenobiotica; the fate of foreign compounds in biological systems.

[66]  Hongqiao Zhang,et al.  Glutathione: overview of its protective roles, measurement, and biosynthesis. , 2009, Molecular aspects of medicine.

[67]  J. Groopman,et al.  Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[68]  D. G. McCarver,et al.  The ontogeny of human drug-metabolizing enzymes: phase II conjugation enzymes and regulatory mechanisms. , 2002, The Journal of pharmacology and experimental therapeutics.

[69]  B Coles,et al.  Effects of modifying structure on electrophilic reactions with biological nucleophiles. , 1984, Drug metabolism reviews.

[70]  Shelly C. Lu Regulation of glutathione synthesis. , 2009, Molecular aspects of medicine.

[71]  G. Szabo,et al.  Alcohol-induced Modulation of Signaling Pathways in Liver Parenchymal and Nonparenchymal Cells: Implications for Immunity , 2009, Seminars in liver disease.

[72]  B. Friguet,et al.  Proteasome function in aging and oxidative stress: implications in protein maintenance failure. , 2006, Antioxidants & redox signaling.

[73]  N. Kitteringham,et al.  The keap1-nrf2 cellular defense pathway: mechanisms of regulation and role in protection against drug-induced toxicity. , 2010, Handbook of experimental pharmacology.

[74]  K. Davies Oxidative Stress, Antioxidant Defenses, and Damage Removal, Repair, and Replacement Systems , 2000, IUBMB life.

[75]  E. Kalinina,et al.  Involvement of thio-, peroxi-, and glutaredoxins in cellular redox-dependent processes , 2008, Biochemistry (Moscow).

[76]  B. Freeman,et al.  Transduction of Redox Signaling by Electrophile-Protein Reactions , 2009, Science Signaling.

[77]  S. Arnesen,et al.  Environmental Health and Toxicology Resources of the United States National Library of Medicine , 2007, Medical reference services quarterly.

[78]  Yan Liu,et al.  The effects of splicing variant of PXR PAR-2 on CYP3A4 and MDR1 mRNA expressions. , 2009, Clinica chimica acta; international journal of clinical chemistry.

[79]  D. Halegoua-DeMarzio,et al.  Drug-induced hepatotoxicity in humans. , 2008 .

[80]  N. Kaplowitz,et al.  Clinical Perspectives on Xenobiotic‐Induced Hepatotoxicity , 2004, Drug metabolism reviews.

[81]  G. Kass Mitochondrial involvement in drug-induced hepatic injury. , 2006, Chemico-biological interactions.

[82]  J. Misdraji Embryology, Anatomy, Histology, and Developmental Anomalies of the Liver , 2010 .

[83]  William M. Lee,et al.  Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. , 2006, Gastroenterology.

[84]  R. Hines,et al.  Ontogeny of human hepatic cytochromes P450 , 2007, Journal of biochemical and molecular toxicology.

[85]  J. Aikens,et al.  Mechanisms and biological relevance of lipid peroxidation initiation. , 1993, Chemical research in toxicology.

[86]  Rafael Radi,et al.  Chemical biology of peroxynitrite: kinetics, diffusion, and radicals. , 2009, ACS chemical biology.

[87]  Irfan Rahman,et al.  Redox modifications of protein-thiols: emerging roles in cell signaling. , 2006, Biochemical pharmacology.

[88]  M. Olivier A haplotype map of the human genome. , 2003, Nature.

[89]  Magnus Ingelman-Sundberg,et al.  The human genome project and novel aspects of cytochrome P450 research. , 2005, Toxicology and applied pharmacology.

[90]  Antonio Colombi,et al.  Toward an "omic" physiopathology of reactive chemicals: thirty years of mass spectrometric study of the protein adducts with endogenous and xenobiotic compounds. , 2009, Mass spectrometry reviews.

[91]  B. Zhivotovsky,et al.  Cell death mechanisms and their implications in toxicology. , 2011, Toxicological sciences : an official journal of the Society of Toxicology.

[92]  M. Boroujerdi,et al.  Biotransformation of Xenobiotics , 2015 .

[93]  M. Schwab,et al.  Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation , 2008, Analytical and bioanalytical chemistry.

[94]  W. Smith Mechanism of Toxicity. , 1970 .

[95]  M. Czaja,et al.  Cell signaling in oxidative stress-induced liver injury. , 2007, Seminars in liver disease.

[96]  R. Mason,et al.  Free radicals in pharmacology and toxicology--selected topics. , 1981, Pharmacological reviews.

[97]  D. Keppler,et al.  Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs , 2008, Expert opinion on drug metabolism & toxicology.

[98]  P. Klatt,et al.  Regulation of protein function by S-glutathiolation in response to oxidative and nitrosative stress. , 2000, European journal of biochemistry.

[99]  J. Hakkola,et al.  Developmental expression of cytochrome P450 enzymes in human liver. , 1998, Pharmacology & toxicology.

[100]  R. Pozos,et al.  Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure-activity relationships. , 2005, Current medicinal chemistry.

[101]  A. Daly Drug-induced liver injury: past, present and future. , 2010, Pharmacogenomics.

[102]  Curtis D. Klaassen,et al.  Casarett and Doull's Toxicology. The Basic Science of Poisons , 1981 .

[103]  J. Turrens Superoxide Production by the Mitochondrial Respiratory Chain , 1997, Bioscience reports.

[104]  Kim L R Brouwer,et al.  Integration of hepatic drug transporters and phase II metabolizing enzymes: mechanisms of hepatic excretion of sulfate, glucuronide, and glutathione metabolites. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[105]  Bernard Testa,et al.  The Biochemistry of Drug Metabolism — An Introduction. Part 4. Reactions of Conjugation and Their Enzymes , 2009 .

[106]  D. Schuppan,et al.  Herbal hepatotoxicity. , 2005, Journal of hepatology.

[107]  Dean P. Jones Redefining oxidative stress. , 2006, Antioxidants & redox signaling.

[108]  N. Kaplowitz Biochemical and Cellular Mechanisms of Toxic Liver Injury , 2002, Seminars in liver disease.

[109]  H. Naegeli,et al.  Role of DNA repair in the protection against genotoxic stress. , 2009, EXS.

[110]  Freya Q. Schafer,et al.  Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple. , 2001, Free radical biology & medicine.

[111]  W. Pryor Free Radicals in Biology , 1976 .

[112]  J. Uetrecht Idiosyncratic drug reactions: past, present, and future. , 2008, Chemical research in toxicology.

[113]  J. Iredale,et al.  Liver fibrosis: cellular mechanisms of progression and resolution. , 2007, Clinical science.

[114]  Peter Neuhaus,et al.  Sex is a major determinant of CYP3A4 expression in human liver , 2003, Hepatology.

[115]  S. Elledge,et al.  The DNA damage response: making it safe to play with knives. , 2010, Molecular cell.

[116]  G. Poli,et al.  4-Hydroxynonenal-protein adducts: A reliable biomarker of lipid oxidation in liver diseases. , 2008, Molecular aspects of medicine.

[117]  Wei Duan,et al.  Drug Bioactivation Covalent Binding to Target Proteins and Toxicity Relevance , 2005, Drug metabolism reviews.

[118]  Michael P. Murphy,et al.  How mitochondria produce reactive oxygen species , 2008, The Biochemical journal.

[119]  M. Cronin,et al.  Metals, toxicity and oxidative stress. , 2005, Current medicinal chemistry.

[120]  J. Uetrecht,et al.  Mechanism of idiosyncratic drug reactions: reactive metabolite formation, protein binding and the regulation of the immune system. , 2002, Current drug metabolism.

[121]  N. Vermeulen,et al.  Role of human glutathione S-transferases in the inactivation of reactive metabolites of clozapine. , 2010, Chemical research in toxicology.

[122]  Tak Yee Aw,et al.  Reactive oxygen species, cellular redox systems, and apoptosis. , 2010, Free radical biology & medicine.

[123]  N. Kaplowitz Mechanisms of liver cell injury. , 2000, Journal of hepatology.

[124]  P. Burcham Genotoxic lipid peroxidation products: their DNA damaging properties and role in formation of endogenous DNA adducts. , 1998, Mutagenesis.

[125]  Wen Xie,et al.  Role of NF-kappaB in regulation of PXR-mediated gene expression: a mechanism for the suppression of cytochrome P-450 3A4 by proinflammatory agents. , 2006, The Journal of biological chemistry.

[126]  M. Trauner,et al.  Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. , 2007, Biochimica et biophysica acta.

[127]  T. Lynch,et al.  The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. , 2007, American family physician.

[128]  Michael P Holt,et al.  Mechanisms of drug-induced liver injury , 2006, The AAPS Journal.

[129]  Wei Li,et al.  Lysosomal proteolysis is the primary degradation pathway for cytosolic ferritin and cytosolic ferritin degradation is necessary for iron exit. , 2010, Antioxidants & redox signaling.

[130]  Steven D. Cohen,et al.  Selective protein covalent binding and target organ toxicity. , 1997, Toxicology and applied pharmacology.

[131]  Yoshiro Saito,et al.  Functional characterization of four naturally occurring variants of human pregnane X receptor (PXR): one variant causes dramatic loss of both DNA binding activity and the transactivation of the CYP3A4 promoter/enhancer region. , 2004, Drug metabolism and disposition: the biological fate of chemicals.

[132]  D. Petersen,et al.  Formation of liver microsomal MDA-protein adducts in mice with chronic dietary iron overload. , 1998, Toxicology letters.

[133]  D. Nelson The Cytochrome P450 Homepage , 2009, Human Genomics.

[134]  M. Pirmohamed,et al.  Are chemically reactive metabolites responsible for adverse reactions to drugs? , 2002, Current drug metabolism.

[135]  L. Laine,et al.  A systematic review of NSAIDs withdrawn from the market due to hepatotoxicity: lessons learned from the bromfenac experience , 2006, Pharmacoepidemiology and drug safety.

[136]  J. Uetrecht,et al.  The danger hypothesis applied to idiosyncratic drug reactions. , 2003, Handbook of experimental pharmacology.

[137]  F. Liu,et al.  Involvement of the immune system in idiosyncratic drug reactions. , 2011, Drug metabolism and pharmacokinetics.

[138]  R. Mason,et al.  CHAPTER 6 – Free-Radical Intermediates in the Metabolism of Toxic Chemicals , 1982 .

[139]  Dominic P. Williams,et al.  Toxicophores: groups and metabolic routes associated with increased safety risk. , 2002, Current opinion in drug discovery & development.

[140]  B. Testa,et al.  The Biochemistry of Drug Metabolism – An Introduction , 2007, Chemistry & biodiversity.

[141]  W. Alrefai,et al.  Bile Acid Transporters: Structure, Function, Regulation and Pathophysiological Implications , 2007, Pharmaceutical Research.

[142]  Defeng Wu,et al.  Oxidative Stress and Alcoholic Liver Disease , 2009, Seminars in liver disease.

[143]  A. Kosters,et al.  The Role of Inflammation in Cholestasis: Clinical and Basic Aspects , 2010, Seminars in liver disease.

[144]  C. Hershey,et al.  Use of complementary and alternative medicines by ambulatory patients. , 2004, Archives of internal medicine.

[145]  R. Benigni Structure-activity relationship studies of chemical mutagens and carcinogens: mechanistic investigations and prediction approaches. , 2005, Chemical reviews.

[146]  D. Keppler,et al.  Interplay of conjugating enzymes with OATP uptake transporters and ABCC/MRP efflux pumps in the elimination of drugs. , 2008, Expert opinion on drug metabolism & toxicology.

[147]  M. Gallogly,et al.  Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. , 2007, Current opinion in pharmacology.

[148]  Sukyeong Lee,et al.  Molecular chaperones in protein quality control. , 2005, Journal of biochemistry and molecular biology.

[149]  Bernard Testa,et al.  The Biochemistry of Drug Metabolism — An Introduction. Part 3. Reactions of Hydrolysis and Their Enzymes , 2007 .

[150]  V. Navarro,et al.  Drug-induced hepatotoxicity in humans. , 2008, Current opinion in drug discovery & development.

[151]  Y. Awasthi,et al.  Human glutathione S-transferases. , 1994, The International journal of biochemistry.

[152]  W. Xie,et al.  Orphan nuclear receptor-mediated xenobiotic regulation in drug metabolism. , 2004, Drug discovery today.

[153]  M. Czaja,et al.  Hepatocytes Sensitized to Tumor Necrosis Factor-α Cytotoxicity Undergo Apoptosis through Caspase-dependent and Caspase-independent Pathways* , 2000, The Journal of Biological Chemistry.

[154]  A. Baird,et al.  Microanatomy of the liver immune system , 2009, Seminars in Immunopathology.

[155]  L. James,et al.  Mechanisms of acetaminophen-induced liver necrosis. , 2010, Handbook of experimental pharmacology.

[156]  B. Testa,et al.  The Biochemistry of Drug Metabolism — An Introduction. Part 5. Metabolism and Bioactivity , 2009 .

[157]  N. Breusing,et al.  Regulation of proteasome-mediated protein degradation during oxidative stress and aging , 2008, Biological chemistry.

[158]  W. S. Baldwin,et al.  Activation of CAR and PXR by Dietary, Environmental and Occupational Chemicals Alters Drug Metabolism, Intermediary Metabolism, and Cell Proliferation. , 2009, Current pharmacogenomics and personalized medicine.

[159]  P. Meier,et al.  Genetic determinants of drug-induced cholestasis and intrahepatic cholestasis of pregnancy. , 2010, Seminars in liver disease.

[160]  J. Uetrecht,et al.  New concepts in immunology relevant to idiosyncratic drug reactions: the "danger hypothesis" and innate immune system. , 1999, Chemical research in toxicology.

[161]  B. Friguet,et al.  Oxidized mitochondrial protein degradation and repair in aging and oxidative stress. , 2010, Antioxidants & redox signaling.

[162]  H. Dienes,et al.  Pathology of Immune-Mediated Liver Injury , 2010, Digestive Diseases.

[163]  D. Green,et al.  Cytoplasmic functions of the tumour suppressor p53 , 2009, Nature.

[164]  D. Pessayre,et al.  Mitochondrial involvement in drug-induced liver injury. , 2010, Handbook of experimental pharmacology.

[165]  Daniel C Liebler,et al.  Protein damage by reactive electrophiles: targets and consequences. , 2008, Chemical research in toxicology.

[166]  J. Gutteridge,et al.  Biological origin of free radicals, and mechanisms of antioxidant protection. , 1994, Chemico-biological interactions.

[167]  S. Korsmeyer,et al.  Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and Death , 2001, Science.

[168]  N. Kaplowitz,et al.  Glutathione in liver diseases and hepatotoxicity. , 2009, Molecular aspects of medicine.

[169]  R. Maronpot,et al.  New Insights into Functional Aspects of Liver Morphology , 2005, Toxicologic pathology.

[170]  M. Trauner,et al.  Role of nuclear receptors in the adaptive response to bile acids and cholestasis: pathogenetic and therapeutic considerations. , 2006, Molecular pharmaceutics.

[171]  S. Mueller,et al.  Compartment-dependent management of H(2)O(2) by peroxisomes. , 2007, Free radical biology & medicine.

[172]  T. Baillie,et al.  Drug-protein adducts: an industry perspective on minimizing the potential for drug bioactivation in drug discovery and development. , 2004, Chemical research in toxicology.